HACKENSACK MERIDIAN HEALTH
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2016-01-01
- Employees
- -
- Market Cap
- -
Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma
- First Posted Date
- 2010-11-16
- Last Posted Date
- 2023-08-22
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 146
- Registration Number
- NCT01241708
- Locations
- 🇺🇸
John Theurer Cancer Center @ Hackensack University Medical Center, Hackensack, New Jersey, United States
Study Examining the Combination of Revlimid (Lenalidomide)and Vidaza (Azacitidine) for Relapsed/Refractory CLL and SLL
- Conditions
- Small Lymphocytic LymphomaChronic Lymphocytic Leukemia(CLL)
- Interventions
- First Posted Date
- 2010-11-16
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 5
- Registration Number
- NCT01241786
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT
- Conditions
- Multiple Myeloma
- Interventions
- Drug: Thalidomide+Melphalan +Bortezomib+stem cell transplant
- First Posted Date
- 2010-11-16
- Last Posted Date
- 2023-01-03
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 29
- Registration Number
- NCT01242267
- Locations
- 🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2008-11-04
- Last Posted Date
- 2022-08-11
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 32
- Registration Number
- NCT00784823
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
PET-CT Scans in Healthy Volunteers After Flu Vaccination
- Conditions
- Flu
- Interventions
- Biological: FluShieldBiological: FluShield - opposite armBiological: FluShield - same armProcedure: Blood DrawsProcedure: FDG PET-CT ScanGenetic: Cytokine Profiling
- First Posted Date
- 2008-10-08
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 18
- Registration Number
- NCT00769002
- Locations
- 🇺🇸
Hackensack Univarsity medical Center, Hackensack, New Jersey, United States
Hold Parameters on Likely Cardiovascular Depressant Medications
- Conditions
- HypotensionAsystoleBradycardia
- First Posted Date
- 2007-09-11
- Last Posted Date
- 2020-08-05
- Lead Sponsor
- Hackensack Meridian Health
- Registration Number
- NCT00527709
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture
- Conditions
- Breast Cancer
- First Posted Date
- 2007-06-01
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 13
- Registration Number
- NCT00481585
- Locations
- 🇺🇸
Hackensack Univeristy Medical Center, Hackensack, New Jersey, United States
A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
- First Posted Date
- 2007-04-23
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 7
- Registration Number
- NCT00464178
- Locations
- 🇺🇸
The Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
Lived Experiences of Adolescents in the Treatment Process of Cancer and the Impact on Occupations
- Conditions
- Pediatric Cancer
- First Posted Date
- 2007-04-04
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 4
- Registration Number
- NCT00456209
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2007-03-14
- Last Posted Date
- 2013-05-13
- Lead Sponsor
- Hackensack Meridian Health
- Registration Number
- NCT00447356
- Locations
- 🇺🇸
The Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States